Equities

Evoqua Water Technologies Corp

Evoqua Water Technologies Corp

Actions
  • Price (MXN)784.88
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Mar 23 2022 10:31 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Evoqua Water Technologies Corp. is a provider of water and wastewater treatment solutions, offering a portfolio of products, services, and expertise to support industrial, municipal, and recreational markets. The Company also supplies engineered equipment packages for high-rate treatment of selenium, nitrate, and metals in water and wastewater. Its Integrated Solutions and Services (ISS) segment provides application-specific solutions and full lifecycle services to treat process water, utility water and wastewater for customers in end markets, including general manufacturing, healthcare, pharmaceuticals, biotech, power, microelectronics, chemical processing, and others. It also provides odor and corrosion control services and drinking water treatment systems for municipalities. It’s Applied Product Technologies segment sells products and technologies, such as filtration, separation, disinfection, wastewater treatment to a set of water treatment system integrators and end users.

  • Revenue in USD (TTM)1.66bn
  • Net income in USD56.92m
  • Incorporated2013
  • Employees4.00k
  • Location
    Evoqua Water Technologies Corp210 Sixth AvenuePITTSBURGH 15222United StatesUSA
  • Phone+1 (724) 772-0044
  • Fax+1 (302) 655-5049
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AQUA:NYQ since
announced
Transaction
value
EPICOR IncDeal completed18 Jul 202218 Jul 2022Deal completed20.84%--
Smith Engineering IncDeal completed22 Jun 202222 Jun 2022Deal completed28.98%--
Frontier Water Systems LLCDeal completed04 Apr 202204 Apr 2022Deal completed-14.53%--
Cantel Medical Corp-Renal BusinessDeal completed20 Dec 202120 Dec 2021Deal completed-9.38%196.30m
Data delayed at least 15 minutes, as of Aug 12 2022 19:19 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.